Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
slight decrease » slight increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
slight decrease » slight increase (Expand Search)
-
2721
-
2722
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2723
-
2724
-
2725
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2726
-
2727
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2728
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2729
-
2730
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2731
-
2732
-
2733
-
2734
-
2735
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2736
-
2737
-
2738
-
2739
Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2740